28 reports

Asthma Forecast and Market Analysis to 2024 TABLE OF CONTENTS (Forecast, Treatment, Epidemiology and Pipeline Datapacks included) ## FORECAST: ASTHMA IN THE US, JAPAN, AND ##EU (Published on ## February 2018) ## EXECUTIVE SUMMARY ## RECENT FORECAST UPDATES ## MARKET DYNAMICS ## FORE

  • Asthma
  • European Union
  • Japan
  • United States
  • Demand

ONE OF THE KEY BENEFITS OF IL-## BIOLOGICS IN ASTHMA IS THEIR IMPACT ON ASTHMA EXACERBATIONS AND HOSPITALIZATIONS.

  • Asthma
  • Respiratory Treatment
  • Therapy
  • ESI Group
  • GlaxoSmithKline plc

Drug Overview: Dulera

9091 10000 7727

Drug Overview: Dulera TABLE OF CONTENTS ## Product Profiles ## Dulera : Asthma LIST OF FIGURES ## Figure ##: Dulera for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Dulera in asthma ## Figure ##: Datamonitor Healthcare’s dr

  • Asthma
  • Hormone
  • Respiratory Treatment
  • Therapy
  • United States

Drug Analysis: Dulera

9091 10000 7727

Drug Analysis: Dulera TABLE OF CONTENTS ## Product Profiles ## Dulera : Asthma LIST OF FIGURES ## Figure ##: Dulera for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Dulera in asthma ## Figure ##: Datamonitor Healthcare’s dru

  • Asthma
  • Hormone
  • Respiratory Treatment
  • Therapy
  • United States

Drug Analysis: Xolair

9091 10000 7727

Drug Analysis: Xolair TABLE OF CONTENTS ## Product Profiles ## Xolair : Asthma LIST OF FIGURES ## Figure ##: Asthma – current and future market dynamics analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Xolair in asthma ## Figure ##: Datamonit

  • Asthma
  • Respiratory Treatment
  • European Union
  • Japan
  • United States

Drug Overview: Xolair

9091 10000 7727

Drug Overview: Xolair TABLE OF CONTENTS ## Product Profiles ## Xolair : Asthma LIST OF FIGURES ## Figure ##: Asthma – current and future market dynamics analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Xolair in asthma ## Figure ##: Datamoni

  • Asthma
  • Respiratory Treatment
  • European Union
  • Japan
  • United States

Drug Overview: QVM149

9091 10000 7727

Drug Overview: QVM## TABLE OF CONTENTS ## Product Profiles ## QVM## : Asthma LIST OF FIGURES ## Figure ##: Spiriva sales for asthma across the US, Japan, and five major EU markets, by country, 2017–## ## Figure ##: Symbicort for asthma – SWOT analysis LIST OF TABLES ## Table

  • Asthma
  • Therapy
  • European Union
  • Japan
  • Demand

Drug Analysis: Singulair TABLE OF CONTENTS ## Product Profiles ## Singulair : Asthma LIST OF FIGURES ## Figure ##: Singulair for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Singulair in asthma ## Figure ##: Datamonitor Health

  • Asthma
  • Respiratory Treatment
  • European Union
  • Japan
  • United States

Drug Overview: Singulair TABLE OF CONTENTS ## Product Profiles ## Singulair : Asthma LIST OF FIGURES ## Figure ##: Singulair for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Singulair in asthma ## Figure ##: Datamonitor Healt

  • Asthma
  • Respiratory Treatment
  • European Union
  • Japan
  • United States

Drug Analysis: Trelegy Ellipta TABLE OF CONTENTS ## Product Profiles ## Trelegy Ellipta : Asthma LIST OF FIGURES ## Figure ##: Trelegy Ellipta for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Trelegy Ellipta in asthma ## Figu

  • Asthma
  • Chronic Disease
  • European Union
  • Japan
  • United States

Drug Overview: Trelegy Ellipta TABLE OF CONTENTS ## Product Profiles ## Trelegy Ellipta : Asthma LIST OF FIGURES ## Figure ##: Trelegy Ellipta for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Trelegy Ellipta in asthma ## Fig

  • Asthma
  • Chronic Disease
  • European Union
  • Japan
  • United States

Drug Overview: Dupixent TABLE OF CONTENTS ## Product Profiles ## Dupixent : Asthma ## Dupixent : Atopic dermatitis LIST OF FIGURES ## Figure ##: Trelegy Ellipta for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Trelegy Ellipta in

  • Asthma
  • European Union
  • Japan
  • United States
  • Demand

Drug Analysis: Dupixent TABLE OF CONTENTS ## Product Profiles ## Dupixent : Asthma ## Dupixent : Atopic dermatitis LIST OF FIGURES ## Figure ##: Trelegy Ellipta for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Trelegy Ellipta in

  • Asthma
  • European Union
  • Japan
  • United States
  • Demand

Drug Analysis: Symbicort TABLE OF CONTENTS ## Product Profiles ## Symbicort : Asthma ## Symbicort : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Symbicort sales for asthma across the US, Japan, and five major EU markets, by country, 2017–## ## Figure ##

  • Asthma
  • European Union
  • Japan
  • United States
  • Demand

Drug Overview: Symbicort TABLE OF CONTENTS ## Product Profiles ## Symbicort : Asthma ## Symbicort : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Symbicort sales for asthma across the US, Japan, and five major EU markets, by country, 2017–## ## Figure ##

  • Asthma
  • European Union
  • Japan
  • United States
  • Demand

Drug Overview: Cinqair

9091 10000 7727

Drug Overview: Cinqair TABLE OF CONTENTS ## Product Profiles ## Cinqair : Asthma LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Xolair in asthma ## Figure ##: Xolair sales for asthma across the US, Japan, and five major EU markets, by coun

  • Asthma
  • Therapy
  • European Union
  • United States
  • Demand

Drug Analysis: Cinqair

9091 10000 7727

Drug Analysis: Cinqair TABLE OF CONTENTS ## Product Profiles ## Cinqair : Asthma LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Xolair in asthma ## Figure ##: Xolair sales for asthma across the US, Japan, and five major EU markets, by count

  • Asthma
  • Therapy
  • European Union
  • United States
  • Demand

Drug Overview: Breo Ellipta TABLE OF CONTENTS ## Product Profiles ## Breo : Chronic obstructive pulmonary disease (COPD) ## Breo Ellipta : Asthma LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Xolair in asthma ## Figure ##: Datamonitor Healthcare’

  • Asthma
  • European Union
  • Japan
  • United States
  • Demand

Drug Analysis: Breo Ellipta TABLE OF CONTENTS ## Product Profiles ## Breo : Chronic obstructive pulmonary disease (COPD) ## Breo Ellipta : Asthma LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Xolair in asthma ## Figure ##: Datamonitor Healthcare’s

  • Asthma
  • European Union
  • Japan
  • United States
  • Demand

Adherium Ltd. ’s Smartinhaler electronic monitoring tool – which incorporates reminder alarms and feedback – used with asthma medication delivery in children with poorly controlled asthma not only helps reduce the frequency of exacerbations, but also improves medication adherence si

  • Asthma
  • Chronic Disease
  • Pathology

Drug Overview: Nucala

9091 10000 7727

Drug Overview: Nucala TABLE OF CONTENTS ## Product Profiles ## Nucala : Asthma ## Nucala : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Spiriva sales for asthma across the US, Japan, and five major EU markets, by country, 2017–## ## Figure ##: Symbicor

  • Asthma
  • European Union
  • Japan
  • United States
  • Product Initiative

Drug Analysis: Nucala

9091 10000 7727

Drug Analysis: Nucala TABLE OF CONTENTS ## Product Profiles ## Nucala : Asthma ## Nucala : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Spiriva sales for asthma across the US, Japan, and five major EU markets, by country, 2017–## ## Figure ##: Symbicort

  • Asthma
  • European Union
  • Japan
  • United States
  • Product Initiative

Drug Analysis: Fasenra

9091 10000 7727

Drug Analysis: Fasenra TABLE OF CONTENTS ## Product Profiles ## Fasenra : Asthma ## benralizumab : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Fasenra for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of F

  • Asthma
  • European Union
  • Japan
  • United States
  • Product Initiative

Drug Overview: Fasenra

9091 10000 7727

Drug Overview: Fasenra TABLE OF CONTENTS ## Product Profiles ## Fasenra : Asthma## benralizumab : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Fasenra for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Fasenra in

  • Asthma
  • European Union
  • Japan
  • United States
  • Product Initiative

Drug Overview: Advair

9091 10000 7727

Drug Overview: Advair TABLE OF CONTENTS ## Product Profiles ## Advair : Asthma ## Advair : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Advair for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Advair in

  • Asthma
  • European Union
  • Japan
  • United States
  • Product Initiative

Drug Analysis: Advair

9091 10000 7727

Drug Analysis: Advair TABLE OF CONTENTS ## Product Profiles ## Advair : Asthma ## Advair : Chronic obstructive pulmonary disease (COPD) LIST OF FIGURES ## Figure ##: Advair for asthma – SWOT analysis ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Advair in

  • Asthma
  • European Union
  • Japan
  • United States
  • Product Initiative

Drug Analysis: Spiriva

9091 10000 7727

It is also approved for use in asthma.

  • Asthma
  • Chronic Disease
  • European Union
  • Japan
  • United States

Drug Overview: Spiriva

9091 10000 7727

It is also approved for use in asthma.

  • Asthma
  • Chronic Disease
  • European Union
  • Japan
  • United States